Use of low molecular heparin for treating osteoarthritis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/715 (2006.01) A61K 31/70 (2006.01) A61K 31/727 (2006.01) A61P 19/02 (2006.01)

Patent

CA 2431709

The invention relates to low molecular heparin for producing medicaments for the prophylaxis and therapy of diseases in the course of which increased activity of at least one of the matrix-metalloproteinases: neutrophilic collagenase, aggrecanase, hADAMTSI and gelatine A are involved.

L'héparine de faible masse moléculaire sert à la fabrication d'agents pharmaceutiques destinés au traitement et à la thérapie de maladies dont l'évolution est liée à une augmentation de l'activité d'au moins une des métalloprotéinases matricielles neutrophiles suivantes : collagénase, aggrécanase, hADAMTSI, et gélatinase A.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of low molecular heparin for treating osteoarthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of low molecular heparin for treating osteoarthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of low molecular heparin for treating osteoarthritis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2052490

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.